The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June ...

LumiThera has released new topline data for its Valeda Light Delivery System to slow the progression of dry age-related ...

A new AI model will be trained on a large set of NHS data in hopes of identifying early interventions for patient care.

The National Institutes of Health (NIH) and the Centers for Medicare & Medicaid Services (CMS) are partnering to develop a ...

GeneDx has completed the acquisition of Fabric Genomics, a US-based company focused on AI-driven human genomic interpretation ...

Eye health company Bausch + Lomb has received the CE Mark approval in Europe for its LuxLife full range of vision intraocular ...

HeartBeam has secured two new US patents, strengthening its intellectual property (IP) portfolio in cardiac monitoring ...

MedTech reveals that Europeans are generally willing to share their healthcare data in exchange for personalised treatment ...

Health Canada has approved Merit Medical Systems’ Wrapsody cell-impermeable endoprosthesis (CIE) device for haemodialysis ...

The company slashed its 2025 earnings forecast due to the ongoing financial fallout from the US-China tariffs.

The Final Rule was mooted for implementation over a staged transition period, determined by a service’s risk level, by 2028.

Natera has announced findings from a study evaluating its Signatera in individuals with soft tissue and bone sarcomas.